Abamectin, doramectin, eprinomectin, ivermectin, milbemectin, and moxidectin in bovine muscle and liver were extracted with acetonitrile. The extracts were partitioned with n-hexane and then evaporated to dryness. The residue was cleaned up on Bond Elute NH 2 cartridge, and the drugs were eluted from the cartridge with methanol-ethyl acetate (3 + 7). The eluate was evaporated to dryness, and residues were derivatized with N,N-dimethylformamide-acetic anhyride-1-methylimidazole. The derivatives were determined by liquid chromatography with fluorescence detection. Recoveries of the 6 drugs were 79.6-63.8% in muscle and 71.6-60.6% in liver at 0.01 ppm levels. The quantitation limits were 5 ppb for each drug.
I
vermectin (IVM), moxidectin (MOX), eprinomectin (EPM), abamectin (ABM), doramectin (DOM), and milbemectin (MIL) are 16-membered macrocyclic lactones, which are used in beef cattle, swine, and sheep as antiparasitic agents. Each drug consists of 2 components, not less than 80% major and not more than 20% minor, except MIL, which is a mixture of MIL A 3 and MIL A 4 (1) . The determination of residual drug content in tissue is particularly important because the contamination of these drugs in food may be a threat to public health. In Japan, IVM, MOX, and EPM residues are monitored in meat-producing animals and each major component is used as a marker to detect residuals of each drug in tissue (2) . Their tolerance levels vary from drug to drug and tissue to tissue (2) .
Determination methods by liquid chromatography (LC) with fluorescence detection of residual IVM (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) , MOX (2, (9) (10) (11) (14) (15) (16) (17) (18) (19) (20) (21) , EPM (2, 11, 15, 17, 18, (22) (23) (24) (25) , ABM (9-11, 13, 14, 16-18, 26) , DOM (9-11, 14-18, 26, 27) , MIL (26) in tissues (2-9, 11, 12, 14-21) , in milk (10) , in plasma (13, 24, 25) , in forest matrixes (25) , or in crops (26) have been already reported. The drugs were also confirmed by LC/mass spectrometry (15, 17-19, 21, 23, 26) . To detect these drugs individually is time-consuming. It is necessary to establish a multiresidual determination method to monitor residual drugs in animal tissues. In this study, residues of IVM, MOX, EPM, ABM, DOM, MIL A 3 , and MIL A 4 in bovine muscle and liver are simultaneously determined by LC with fluorescence detection after derivatization with N,N-dimethylformamide (DMF)-acetic anhydride-1-methylimidazole. (i) Stock standard solutions.-100 mg/mL. Prepare individual stock standard solutions by dissolving each 10 mg standard in methanol. The individual stock solutions were stored at -20°C.
METHOD

Apparatus
(j) Mixed working standard solution.-Pipet 1.0 mL of each stock standard solution to 100 mL volumetric flask and dilute to 100 mL with MeCN (each 1 mg/mL). Dilute this mixed standard solution with MeCN. Calibration standards in the range of 0.005-0.5 mg/mL are prepared by pipetting working solution into a flask and reducing to dryness. They are derivatized as outlined in the sample determination (MeCN was previously dehydrated by molecular sieves).
Extraction and Cleanup
Accurately weigh 5 g homogenized tissue in 100 mL centrifuge tubes. Add 10 g anhydrous sodium sulfate and 25 mL MeCN, and homogenize for 2 min; then centrifuge at 2500 rpm for 10 min. Decant the supernatant into 100 mL separatory funnel and add 25 mL n-hexane saturated with MeCN. Shake the separatory funnel vigorously for 5 min and let stand until 2 phases separate completely. Collect lower MeCN phase in 200 mL round-bottom flask. Re-extract precipitate with another 25 mL MeCN, homogenize, centrifuge, and add supernatant to separatory funnel. Shake separatory funnel vigorously for 5 min and let stand until 2 phases separate completely. Combine lower phase in the 200 mL round-bottom flask, add 8 mL n-propane, and evaporate to dryness (or as dry as possible) on rotary evaporator at 40°C.
Dissolve residue with 4 mL n-hexane and set ultrasonic bath for 5 s. Apply n-hexane to preconditioned column by using a disposable Pasteur pipet. Elute solution to top of column, and discard eluate. Rinse flask with additional 4 mL n-hexane and apply this to the column, just as the first 4 mL is existing in the column; continue to elute, and discard all of the above rinses. Rinse flask with 5 mL methanol-ethyl acetate (3 + 7) solution, apply to column, collect eluate in 50 mL round-bottom flask, and evaporate to dryness completely on rotary evaporator at 40°C.
Derivatization
Add 0.2 mL freshly prepared derivatization reagent to flask, mix on a Vortex mixer vigorously for 5 s, cap tightly, and incubate in oven at 100°C for 90 min. Remove flask, cool,
Results and Discussion
Maximum residue levels (MRLs) of EPM, MOX, ABM, DOM, and IVM, set by Japan, the United States, the European Union, Canada, and Food Agricultural Organization/World Health Organization, vary from drug to drug and tissue to tissue. Therefore, in this study, the determination method was designed to cover each drug at a level closer to its tolerance level.
The drugs were extracted from tissues with acetone-water-isooctane (2, 4, 16), ethyl acetate (10, 25), methylene chloride-acetone (22, 23) , acetone (26) , and MeCN (5, 6, 8, 9, 11-15, 17-21, 24). A matrix solid-phase dispersion (MSPD) method, using C 18 , was also developed (3, 7, 20) . In this study, the drugs were extracted from tissues with MeCN.
In cleanup procedures of extracts from tissues, SPE stationary phases, basic alumina (3, 5, 11, 13, (16) (17) (18) 20) this study, at first, lipids in the extract were removed by partitioning with n-hexane saturated with MeCN. To decrease volume of solvent in the cleanup step, SPE procedure, a Bond Elute NH 2 cartridge was used. After the extract was evaporated, the residue was dissolved in 4 mL n-hexane, loaded on the column, and then rinsed with additional 4 mL n-hexane. No drugs were eluted from the column by 8 mL n-hexane. When ethyl acetate was applied to the column, some of the drugs were eluted. Almost all kinds of drugs were eluted by methanol-ethyl acetate (1 + 9) solution to some extent, and all drugs were completely eluted from the column by 5 mL methanol-ethyl acetate (3 + 7) solution.
In the derivatization step, these drugs were derivatized with a mixture of DMF-acetic anhydride-1-methylimidazole (2) (3) (4) (5) 19) or trifluoroacetic anhydride (TFAA)-1-methylimidazole (6-14, 16, 17, 20, 22, 24-27) . When TFAA-1-methylimidazole was used for derivatization, each drug, except EPM, reacted quickly. However, EPM was not derivatized soon at room temperature. It took about 80-90 min to complete EPM derivatization at 85°C. Moreover, the derivative of EPM did not show a sharp single peak with this LC operating condition. Danaher et al. (17) reported that EPM was satisfactory derivatized with TFAA-1-methylimidazole by heating at 65°C for 30 min in the presence of acetic acid. We used the former derivatization method, DMF-acetic anhydride-1-methylimidazole reaction solution. All 6 drugs showed sharp peaks in the liquid chromatogram, with derivatization at 100°C for 90 min. After derivatization, a little dark and opaque derivative was diluted with a relatively large volume (5 mL) of MeCN in order to skip the cleanup step of derivatives with silica gel (2-5), C 18 (6), or Florisil cartridges (19) . Without those SPE cleanup steps, LC column pressure was kept constant and each retention time of each drug was stable after about 400 injections of sample and/or standard solutions. Each derivatized drug diluted in 5 mL MeCN was stable about 24 h in a dark place at room temperature.
To optimize separation of the drugs, several mobile phase compositions were investigated. By adjusting the LC mobile phase composition, MeCN-THF-water (96 + 3 + 1), the retention times of 6 drugs can be controlled. The retention times and relative standard deviations (RSDs) of 6 drugs (n = 10) were as follows: EPM, Representative liquid chromatograms of standards, blank liver, blank muscle, fortified liver, and muscle are shown in Figure 1 . There were no interfering peaks on chromatograms to disturb residual drug determination.
As a precision test, fortified sample liver sets, at levels of 0.01 and 0.05 ppm, consisting of 5 replicates at each level and 1 blank control, were run on Days 1 and 3. Fortified sample muscle sets, at levels of 0.01 and 0.05 ppm, consisting of 5 replicates at each level and 1 blank control, were run on Days 2 and 4. A 100 mL volume (0.5 or 2.5 mg/mL) of mixed standard solution was added to each 5 g portion of liver or muscle; samples were allowed to sit for 30 min in a dark place before extraction and were then analyzed as described above. Recovery calculations were based on a 5-point calibration mixed standard curve. Table 1 shows the results of precision tests. Overall recovery (n = 20) and RSD of the drugs from liver after fortification of 0.01 and 0.05 ppm of each were 76.7-60.6%, and 8.44-2.04%, respectively, and from muscle were 92.5-63.8% and 8.88-1.43%, respectively. A calibration curve was constructed by plotting peak area versus drug concentration. Those of AVM, DOM, IVM, MIL A 3 , MOX, EPM, and MIL A 4 were linear over the range of 0.005-0.5 mg/5 mL with correlation coefficients ( = 0.998, 0.998, 0.998, 0.998, 0.999, 0.998, and 0.998, respectively.
Each detection limit, based on 3 times the baseline noise from the blank sample, was 0.6 ppb for AVM, DOM, IVM, MOX, and 1.2 ppb for EPM and MIL. Each limit of quantitation, based on 10-20 multiple of the baseline noise, was 5 ppb for all 6 drugs.
In conclusion, the proposed analytical method provides a useful tool for the simultaneous determination of AVM, DOM, IVM, MOX, EPM, and MIL in bovine muscle and liver.
